Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
NCT ID: NCT04674969
Last Updated: 2025-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2021-03-29
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical Cohort
All enrolled patients are included in the Clinical Cohort. Patients will complete assessments per standard of care through 2-year follow-up in Australia, Austria, Canada, France, Germany, Poland, Spain, Taiwan, Thailand, and the United States. Patients will complete assessments per standard of care through 5-year follow-up in China.
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Ranger™ Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter; ELUVIA™ Drug-Eluting Vascular Stent System
Outcomes Cohort
Patients at select sites will complete the Clinical Cohort standard of care assessments and additional assessments as part of the Outcomes Cohort, including Quality of Life questionnaires, six-minute walk test (6MWT), and Healthcare Utilization data collection.
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Ranger™ Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter; ELUVIA™ Drug-Eluting Vascular Stent System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Ranger™ Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter; ELUVIA™ Drug-Eluting Vascular Stent System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent (patient data release-form)
* Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Bernard's Medical Center
Jonesboro, Arkansas, United States
PIH Health Good Samaritan Hospital
Los Angeles, California, United States
Cedars - Sinai Medical Center
Los Angeles, California, United States
Ronald Reagan UCLA Medical Center
Los Angeles, California, United States
Sutter Medical Center, Sacramento
Sacramento, California, United States
Adventist Health St Helena Hospital
St. Helena, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Christiana Hospital
Newport, Delaware, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Palm Beach Heart & Vascular, LLC
Boynton Beach, Florida, United States
Tallahassee Memorial Hospital
Tallahassee, Florida, United States
Emory University Hospital
Atlanta, Georgia, United States
South Georgia Medical Center
Valdosta, Georgia, United States
Rush University
Chicago, Illinois, United States
St. John's Hospital/ Prairie Education and Research Cooperative
Springfield, Illinois, United States
St. Joseph Hospital/Dupont Hospital
Fort Wayne, Indiana, United States
Ascension St. Vincent's Hospital
Indianapolis, Indiana, United States
CIS Clinical Research Corporation
Houma, Louisiana, United States
Ochsner Clinic Foundation
Kenner, Louisiana, United States
Cardiovascular Institute of the South
Lafayette, Louisiana, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Mercy Hospital (Allina Health)
Coon Rapids, Minnesota, United States
North Mississippi Medical Center
Tupelo, Mississippi, United States
Deborah Heart & Lung Center
Browns Mills, New Jersey, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Newark Beth Israel Medical Center
Newark, New Jersey, United States
Buffalo General Hospital
Buffalo, New York, United States
North Shore University Hospital/Northwell Health
Manhasset, New York, United States
New York University Medical Center
New York, New York, United States
Columbia University
New York, New York, United States
Mount Sinai
New York, New York, United States
Memorial Sloan Kettering Hospital
New York, New York, United States
Weill Cornell Medicine/New York-Presbyterian Hospital
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Rex UNC Health (NC Heart and Vascular Research, LLC)
Raleigh, North Carolina, United States
University Hospitals of Cleveland
Cleveland, Ohio, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Premier Cardiovascular Institute
Dayton, Ohio, United States
Ascension St. John Clinical Research Institute
Tulsa, Oklahoma, United States
Pinnacle Health Cardiovascular Institute
Harrisburg, Pennsylvania, United States
Hospital University of Pennsylvania
Philadelphia, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
The Miriam Hospital
Providence, Rhode Island, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Monument Health Rapid City Hospital, Inc.
Rapid City, South Dakota, United States
Seton Medical Center
Austin, Texas, United States
The University of Texas, Southwestern Medical Center
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
HeartPlace P.A.
Plano, Texas, United States
Inova Fairfax Hospital
Fairfax, Virginia, United States
UW Medicine - Harborview Medical Center
Seattle, Washington, United States
Royal Perth Hospital
Perth, Western Australia, Australia
Royal North Shore Hospital
St Leonards, , Australia
Medizinische Univ.-Kliniken Graz
Graz, , Austria
Peter Lougheed Centre-Hospital
Calgary, Alberta, Canada
CHUS - Hotel Dieu
Sherbrooke, Quebec, Canada
Beijing Anzhen Hospital of the Capital University of Medical Sciences
Chaoyang, Beijing Municipality, China
China-Japan Friendship Hospital
Chaoyang, Beijing Municipality, China
Xuanwu Hospital Capital Medical University
Xicheng, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Zhongshan University No.1 Hospital
Guangzhou, Guangdong, China
Affiliated Hospital of Medical College Qingdao University
Qingdao, Shandong, China
Shanghai Ninth People's Hospital - Shanghai Jiaotong University School of Medicine
Huangpu, Shanghai Municipality, China
Shanghai Changhai Hospital
Yangpu, Shanghai Municipality, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
First Affiliated Hospital of Medical College of Xi'an Jiaotong University
Xi’an, Shanxi, China
Shanghai Zhongshan Hospital
Shanghai, Xuhui District, China
Hospital Marie Lannelongue
Le Plessis-Robinson, , France
Hospital Paris Saint Joseph
Paris, , France
Fürst Stirum Klinik Bruchsal Hospital
Bruchsal, , Germany
University Clinic Essen-Hospital
Essen, , Germany
Klinikum der Ludwig-Maximilians-Universitat
München, , Germany
Uniwersyteckim Szpitalem Klinicznym w Poznaniu
Poznan, , Poland
Corporacio Sanitaria Parc Taulí, Barcelona
Sabadell, , Spain
China Medical University Hospital
Taichung, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Siriraj Hospital Department of Surgery
Bangkok, , Thailand
Prince of Songkla University
Hat Yai, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dawn Salvatore
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Secemsky EA, Giri J, Brodmann M, Goueffic Y, Fu W, Greenberg-Worisek AJ, Jaff MR, Kirksey L, Kohi MP. Implementing methods in the ELEGANCE registry to increase diversity in clinical research. J Vasc Surg. 2024 Jan;79(1):136-145.e3. doi: 10.1016/j.jvs.2023.08.131. Epub 2023 Sep 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S2444
Identifier Type: -
Identifier Source: org_study_id